| Website | hxdiagnostics.com |
| Category | BioTech |
| Phone | 510-652-4931 |
| Employees | |
| Description | Rapid Diagnostics |
| TOTAL | $7.8M |
| VENTURE FUNDING TOTAL | $7.8M |
| Series A, 2/09 Kleiner Perkins Caufield & Byers Nanogen | $3.1M |
| Series B, 9/09 | $4.7M |
HX Diagnostics is a San Francisco Bay Area diagnostics company with a mission to be a global leader in rapid diagnostics for seasonal and emerging infectious diseases. The company is focused on the development and commercialization of seasonal and pandemic influenza assays that will allow clinicians to make rapid assessments of their patient’s health status. HX Diagnostics has relationships with leading avian flu researchers across the globe. The company and its global collaborators share a common focus to bring the first highly effective differentiated point-of-care diagnostic product to simultaneously detect multiple strains of influenza.
